
Scott Gottlieb
Scott Gottlieb is a physician and former government official who served as the Commissioner of the U.S. Food and Drug Administration (FDA) from 2017 to 2021 under President Donald Trump. He is known for his expertise in public health and pharmaceutical policy, and has been a vocal advocate for addressing health issues such as the opioid crisis and the regulation of e-cigarettes. Gottlieb has also been involved in discussions surrounding the COVID-19 pandemic and has provided insights on health policy in various media outlets. Recently, he commented on the Trump administration's plans to revive Title 42, expressing concern about the use of public health measures in immigration policy.
Country presence
Recent news mentions
Scott Gottlieb, former FDA commissioner, discussed the potential sources of contamination related to cyclospora outbreaks.
Trump pone trabas para importar productos mexicanos; argumenta riesgos de salud y seguridadScott Gottlieb mentioned that the outbreak of cyclosporiasis could have originated from cilantro and parsley from Mexico.
Aguacates, lechuga y jalapeños, la "ensalada" de productos mexicanos cuestionados y vetados por EUScott Gottlieb, the former Food and Drug Administration commissioner, warned that the shift of clinical trials to Asia could undermine innovation in the US.
China’s latest boom is sounding alarm bells in AmericaScott Gottlieb praised Peter Marks for his extraordinary progress in medical advancements.
Governo Trump força renúncia de Peter Marks, principal cientista de vacinas de agência governamentalDr. Scott Gottlieb, former commissioner of the FDA, expressed uncertainty about the government's use of a public health measure.
Trump se prepara para revivir Título 42; alegaría riesgo de propagación de enfermedades como tuberculosis












